UNIVERSITY OF SOUTHERN CALIFORNIA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1880-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://startusc.com
Erector Spinae Plane Block for Rib Fracture Analgesia in the Emergency Department
Not Applicable
- Conditions
- Rib Fracture Multiple
- Interventions
- Procedure: Erector Spinae Plane BlockDrug: IV Analgesia
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2021-05-19
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 40
- Registration Number
- NCT04892563
Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)
Phase 2
Active, not recruiting
- Conditions
- Aneurysm, RupturedDelayed Cerebral IschemiaBlood Brain Barrier DefectVasospasm, Intracranial
- First Posted Date
- 2021-05-06
- Last Posted Date
- 2023-02-10
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 20
- Registration Number
- NCT04876638
- Locations
- 🇺🇸
University of Southern California Department of Neurosurgery, Los Angeles, California, United States
Danazol for Treatment of Cytopenias in Patients With Cirrhosis
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 10
- Registration Number
- NCT04873102
- Locations
- 🇺🇸
Keck Hosital of USC, Los Angeles, California, United States
Late Preterm Corticosteroids and Neonatal Hypoglycemia
- First Posted Date
- 2021-05-03
- Last Posted Date
- 2021-05-03
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 210
- Registration Number
- NCT04869709
- Locations
- 🇺🇸
LAC+USC Medical Center, Los Angeles, California, United States
UltraMTP in Adult Trauma Patients Undergoing Surgery Within 24 Hours: Effects on Mortality and Clinical Outcomes
Completed
- Conditions
- Blood Transfusion ComplicationDeathTrauma
- Interventions
- Other: Blood transfusion
- First Posted Date
- 2021-04-30
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 3000
- Registration Number
- NCT04866953
- Locations
- 🇺🇸
Keck School of Medicine of the University of Southern California, Los Angeles, California, United States
Virtual Reality Guided Imagery for Chronic Pain
Not Applicable
Completed
- Conditions
- Back PainComplex Regional Pain Syndromes
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 36
- Registration Number
- NCT04849897
- Locations
- 🇺🇸
USC Pain Center, Keck School of Medicine, Los Angeles, California, United States
Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor
Phase 4
Completed
- Conditions
- Drug Drug Interaction
- Interventions
- Drug: Trikafta [orange tablet containing ELX 100mg, TEZ 50mg, and IVA 75mg]
- First Posted Date
- 2021-04-12
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 6
- Registration Number
- NCT04840862
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
Medical and Psychosocial Issues in Adolescents and Young Adults With Colorectal Cancer
Not Applicable
Terminated
- Conditions
- Stage IIC Colorectal Cancer AJCC v8Stage III Colorectal Cancer AJCC v8Stage IIIA Colorectal Cancer AJCC v8Stage I Colorectal Cancer AJCC v8Stage II Colorectal Cancer AJCC v8Stage IIA Colorectal Cancer AJCC v8Stage IIB Colorectal Cancer AJCC v8Stage IIIB Colorectal Cancer AJCC v8Stage IIIC Colorectal Cancer AJCC v8Stage IVC Colorectal Cancer AJCC v8
- Interventions
- Procedure: Biospecimen CollectionOther: Medical Chart ReviewOther: Physical Performance TestingOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2021-04-06
- Last Posted Date
- 2022-08-24
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 32
- Registration Number
- NCT04832763
- Locations
- 🇺🇸
Los Angeles County-USC Medical Center, Los Angeles, California, United States
🇺🇸USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Dasatinib for the Treatment of Moderate and Severe COVID-19
Phase 2
Withdrawn
- Conditions
- Symptomatic COVID-19 Infection Laboratory-Confirmed
- Interventions
- Drug: Placebo Administration
- First Posted Date
- 2021-04-05
- Last Posted Date
- 2022-08-10
- Lead Sponsor
- University of Southern California
- Registration Number
- NCT04830735
- Locations
- 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Cognition and Motor Learning Post-stroke
Early Phase 1
Recruiting
- Conditions
- StrokeCVA (Cerebrovascular Accident)
- Interventions
- Behavioral: Explicit motor learningBehavioral: Implicit motor learning
- First Posted Date
- 2021-04-02
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 65
- Registration Number
- NCT04829071
- Locations
- 🇺🇸
Center for Health Professions, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath